JOMPAC

Journal of Medicine and Palliative Care (JOMPAC) is an open access scientific journal with independent, unbiased, and double-blind review under international guidelines. The purpose of JOMPAC is to contribute to the literature by publishing articles on health sciences and medicine.

EndNote Style
Index
Original Article
Systemic immune inflammation indices: novel predictors for preterm premature rupture of membranes and associated complications
Aims: This study aimed to investigate the relationship between systemic immune inflammation (SII) and response indices (SIRI), which are new markers of systemic inflammation derived from immune cells, and preterm premature rupture of membranes (PPROM), as well as adverse pregnancy outcomes.
Methods: The retrospective study included 75 women with singleton pregnancies complicated by PPROM between the 24th and 34th gestational week and 75 healthy pregnant women who delivered at term without any additional diseases (control group). Inflammation indices were calculated based on neutrophil (N), platelet (P), lymphocyte (L), and monocyte (M) counts as follows: The neutrophil-to-lymphocyte ratio (NLR)=N/L; the platelet-to-lymphocyte ratio (PLR)=P/L; SII=(N×P)/L; and SIRI=(N×M)/L.
Results: The median NLR (4.8 vs. 3.5, p <0.001), median PLR (145.1 vs. 126.5, p<0.001), median SII (1208.6 vs. 807.4, p<0.001), and median SIRI (3.1 vs. 2.0, p<0.001) were higher in the PPROM group compared to the control group. Multiple logistic regression analysis showed that increased SIRI (OR= 7.05, p=0.010), as well as increased C-reactive protein levels were determined as independent predictors of PPROM. In the PPROM group, the SIRI was higher in the presence of combined complications compared to without complications (3.4 vs. 2.5, p<0.001). The SIRI showed superior diagnostic performance in predicting the presence and complications of PPROM compared to other inflammation indices.
Conclusion: The PPROM group had higher leukocyte-based inflammation indices compared to the control group. Due to the superior diagnostic performance of the SIRI in distinguishing both PPROM and combined complications compared to other leukocyte-based inflammation indices, it may serve as a significant screening tool for PPROM.


1. Committee on Practice B-O. ACOG practice bulletin no. 188:Prelabor Rupture of Membranes. Obstet Gynecol. 2018;131(1):e1-e14. doi: 10.1097/AOG.0000000000002455
2. Garg A, Jaiswal A. Evaluation and management ofpremature rupture of membranes: a review article. Cureus.2023;15(3):e36615. doi: 10.7759/cureus.36615
3. Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm ruptureof membranes. Cochrane Database Syst Rev. 2010(8):CD001058.doi: 10.1002/14651858.CD001058.pub2
4. Galaz J, Romero R, Slutsky R, et al. Cellular immune responsesin amniotic fluid of women with preterm prelabor rupture ofmembranes. J Perinat Med. 2020;48(3):222-233. doi: 10.1515/jpm-2019-0395
5. Romero R, Miranda J, Chaemsaithong P, et al. Sterile andmicrobial-associated intra-amniotic inflammation in pretermprelabor rupture of membranes. J Matern Fetal Neonatal Med.2015;28(12):1394-1409. doi: 10.3109/14767058.2014.958463
6. Polettini J, Silva MG, Kacerovsky M, Syed TA, Saade GR, MenonR. Screening of lysyl oxidase (LOX) and lysyl oxidase like (LOXL)enzyme expression and activity in preterm prelabor rupture offetal membranes. J Perinat Med. 2016;44(1):99-109. doi: 10.1515/jpm-2014-0337
7. Menon R, Behnia F, Polettini J, Richardson LS. Novel pathwaysof inflammation in human fetal membranes associated withpreterm birth and preterm pre-labor rupture of the membranes.Semin Immunopathol. 2020;42(4):431-450. doi: 10.1007/s00281-020-00808-x
8. Musilova I, Kutova R, Pliskova L, et al. Intraamnioticinflammation in women with preterm prelabor rupture ofmembranes. PLoS One. 2015;10(7):e0133929. doi: 10.1371/journal.pone.0133929
9. Rosales C. Neutrophil: a cell with many roles in inflammationor several cell types? Front Physiol. 2018;9:113. doi: 10.3389/fphys.2018.00113
10. Etyang AK, Omuse G, Mukaindo AM, Temmerman M. Maternalinflammatory markers for chorioamnionitis in preterm prelabourrupture of membranes: a systematic review and meta-analysisof diagnostic test accuracy studies. Syst Rev. 2020;9(1):141. doi:10.1186/s13643-020-01389-4
11. Le Ray I, Mace G, Sediki M, et al. Changes in maternal bloodinflammatory markers as a predictor of chorioamnionitis:a prospective multicenter study. Am J Reprod Immunol.2015;73(1):79-90. doi: 10.1111/aji.12323
12. Back JH, Kim SY, Gu MB, et al. Proteomic analysis of plasma toidentify novel biomarkers for intra-amniotic infection and/orinflammation in preterm premature rupture of membranes. SciRep. 2023;13(1):5658. doi: 10.1038/s41598-023-32884-y.
13. Esercan A, Demir I. Neutrophil/lymphocyte and platelet/lymphocyte ratio in preterm premature rupture of membranes.Cureus. 2023;15(5):e38664. doi: 10.7759/cureus.38664
14. Ozel A, Alici Davutoglu E, Yurtkal A, Madazli R. How do platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio changein women with preterm premature rupture of membranes, andthreaten preterm labour? J Obstet Gynaecol. 2020;40(2):195-199.doi: 10.1080/01443615.2019.1621807
15. Bodaghi A, Fattahi N, Ramazani A. Biomarkers: Promising andvaluable tools towards diagnosis, prognosis and treatment ofCovid-19 and other diseases. Heliyon. 2023;9(2):e13323. doi:10.1016/j.heliyon.2023.e13323
16. Indrayan A, Vishwakarma G, Verma S, Sarmukaddam S, Tyagi A.Quest for biomarkers of positive health: a review. Indian J CommunityMed. 2023;48(3):382-389. doi: 10.4103/ijcm.ijcm_480_22
17. Gunduz O, Seven B, Ozgu-Erdinc AS, et al. Correlation ofsystemic inflammation biomarkers and disease severity inpregnant women with COVID-19. Rev Assoc Med Bras (1992).2023;69(6):e20221614. doi: 10.1590/1806-9282.20221614
18. Lombardi A, Duiella S, Li Piani L, et al. Inflammatory biomarkersin pregnant women with COVID-19: a retrospective cohort study.Sci Rep. 2021;11(1):13350. doi: 10.1038/s41598-021-92885-7
19. Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammationindex predicts prognosis of patients after curative resection forhepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212-6222. doi: 10.1158/1078-0432.CCR-14-0442
20. Qi Q, Zhuang L, Shen Y, et al. A novel systemic inflammationresponse index (SIRI) for predicting the survival ofpatients with pancreatic cancer after chemotherapy. Cancer.2016;122(14):2158-2167. doi: 10.1002/cncr.30057
21. Yun S, Yi HJ, Lee DH, Sung JH. Systemic inflammation responseindex and systemic immune-inflammation index for predictingthe prognosis of patients with aneurysmal subarachnoidhemorrhage. J Stroke Cerebrovasc Dis. 2021;30(8):105861. doi:10.1016/j.jstrokecerebrovasdis.2021.105861
22. Li J, He D, Yu J, et al. Dynamic status of SII and SIRI alters therisk of cardiovascular diseases: evidence from kailuan cohortstudy. J Inflamm Res. 2022;15:5945-5957. doi: 10.2147/JIR.S378309
23. Krawczyk P, Sioma-Markowska U. Nutrition quality of pregnantwomen based on body mass index and the content of selectednutrients and energy in the daily diet. Ginekol Pol. 2021. doi:10.5603/GP.a2021.0069
24. Committee on Practice B-O. ACOG Practice Bulletin No.199: Use of prophylactic antibiotics in labor and delivery.Obstet Gynecol. 2018;132(3):e103-e119. doi: 10.1097/AOG.0000000000002833
25. Quinn JA, Munoz FM, Gonik B, et al. Preterm birth:Case definition &amp; guidelines for data collection, analysis,and presentation of immunisation safety data. Vaccine.2016;34(49):6047-6056. doi: 10.1016/j.vaccine.2016.03.045
26. Schober P, Boer C, Schwarte LA. Correlation coefficients:appropriate use and interpretation. Anesth Analg.2018;126(5):1763-1768. doi: 10.1213/ANE.0000000000002864
27. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparingthe areas under two or more correlated receiver operatingcharacteristic curves: a nonparametric approach. Biometrics.1988;44(3):837-845.
28. Areia AL, Moura P, Mota-Pinto A, CRD PNm. The role ofinnate immunity in spontaneous preterm labor: A systematicreview. J Reprod Immunol. 2019;136:102616. doi: 10.1016/j.jri.2019.102616
29. Menon R, Fortunato SJ. Infection and the role of inflammationin preterm premature rupture of the membranes. Best PractRes Clin Obstet Gynaecol. 2007;21(3):467-478. doi: 10.1016/j.bpobgyn.2007.01.008
30. Vadillo-Ortega F, Estrada-Gutierrez G. Role of matrixmetalloproteinases in preterm labour. BJOG. 2005;112 Suppl1:19-22. doi: 10.1111/j.1471-0528.2005.00579.x
31. Bouvier D, Forest JC, Blanchon L, et al. Risk factors andoutcomes of preterm premature rupture of membranes in acohort of 6968 pregnant women prospectively recruited. J ClinMed. 2019;8(11):1987. doi: 10.3390/jcm8111987
32. Jena BH, Biks GA, Gete YK, Gelaye KA. Incidence of pretermpremature rupture of membranes and its association withinter-pregnancy interval: a prospective cohort study. Sci Rep.2022;12(1):5714. doi: 10.1038/s41598-022-09743-3
33. Musilova I, Pliskova L, Gerychova R, et al. Maternal whiteblood cell count cannot identify the presence of microbialinvasion of the amniotic cavity or intra-amniotic inflammationin women with preterm prelabor rupture of membranes. PLoSOne. 2017;12(12):e0189394. doi: 10.1371/journal.pone.0189394
34. Yoon BH, Jun JK, Park KH, Syn HC, Gomez R, Romero R.Serum C-reactive protein, white blood cell count, and amnioticfluid white blood cell count in women with preterm prematurerupture of membranes. Obstet Gynecol. 1996;88(6):1034-1040.doi: 10.1016/s0029-7844(96)00339-0
35. Eri&ccedil; Horasanlı J, Alp EC, B&uuml;lb&uuml;l R. Evaluation of complete bloodcell count parameters in the diagnosis of threatened pretermlabor and premature rupture of membranes. Dubai Med J.2022;5(3):157-162.
36. Koseoglu SB, Guzel AI, Deveer R, et al. Maternal serum amyloidA levels in pregnancies complicated with preterm prelabourrupture of membranes. Ginekol Pol. 2014;85(7):516-520. doi:10.17772/gp/1763
37. Ekin A, Gezer C, Kulhan G, Avci ME, Taner CE. Can plateletcount and mean platelet volume during the first trimester ofpregnancy predict preterm premature rupture of membranes? JObstet Gynaecol Res. 2015;41(1):23-28. doi: 10.1111/jog.12484
38. Uckan K, Baskiran Y, Celegen I. Association of subclinicalmarkers of inflammation with preterm premature rupture ofmembranes and adverse neonatal results: a case control study.Arch Gynecol Obstet. 2022;306(6):2063-2068. doi: 10.1007/s00404-022-06756-1
39. Toprak E, Bozkurt M, Dincgez Cakmak B, et al. Platelet-to-lymphocyte ratio: A new inflammatory marker for the diagnosisof preterm premature rupture of membranes. J Turk Ger GynecolAssoc. 2017;18(3):122-126. doi: 10.4274/jtgga.2017.0028
40. Sharami SH, Biazar G, Farzi F, et al. The association betweenplatelets/lymphocyte ratio and premature rupture of membranes.Int J Women&rsquo;s Health Reprod Sci. 2021;9(1):80-83.
41. Badimon L, Pena E, Arderiu G, et al. C-reactive protein inatherothrombosis and angiogenesis. Front Immunol. 2018;9:430.doi: 10.3389/fimmu.2018.00430
42. Su Y, Gao J, Kaur P, Wang Z. Neutrophils and macrophages astargets for development of nanotherapeutics in inflammatorydiseases. Pharmaceutics. 2020;12(12):1222. doi: 10.3390/pharmaceutics12121222
43. Dundar B, Dincgez Cakmak B, Ozgen G, Tasgoz FN, Guclu T,Ocakoglu G. Platelet indices in preterm premature rupture ofmembranes and their relation with adverse neonatal outcomes.J Obstet Gynaecol Res. 2018;44(1):67-73. doi: 10.1111/jog.13484
44. Mercer BM. Preterm premature rupture of the membranes. ObstetGynecol. 2003;101(1):178-193. doi: 10.1016/s0029-7844(02)02366-9
45. Xie A, Zhang W, Chen M, et al. Related factors and adverseneonatal outcomes in women with preterm premature rupture ofmembranes complicated by histologic chorioamnionitis. Med SciMonit. 2015;21:390-395. doi: 10.12659/MSM.891203
46. Tanacan A, Uyanik E, Unal C, Beksac MS. A cut-off value forsystemic immune-inflammation index in the prediction ofadverse neonatal outcomes in preterm premature rupture of themembranes. J Obstet Gynaecol Res. 2020;46(8):1333-1341. doi:10.1111/jog.14320
Volume 4, Issue 5, 2023
Page : 516-523
_Footer